Status:
COMPLETED
Study of Sildenafil in Patient With Heart Failure.
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine if sildenafil (Viagra) improves exercise tolerance.
Detailed Description
Patients will undergo an exercise stress test. One dose of Sildenafil will then be given, followed by a one hour rest period. A repeat exercise stress test will then be repeated.
Eligibility Criteria
Inclusion
- Age 18 - 75 Ejection fraction \<35% Heart failure limited by fatigue and shortness of breath -
Exclusion
- Inability to exercise. Patients with shortness of breath while resting. Patient requiring intravenous medication. Patients taking the following medications: nitroglycerine pill/patch/paste, isordil and Imdur
- \-
Key Trial Info
Start Date :
December 1 2001
Trial Type :
INTERVENTIONAL
End Date :
February 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00309816
Start Date
December 1 2001
End Date
February 1 2006
Last Update
April 3 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114